机构:[1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore[2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore[3]Duke-NUS Medical School, National University of Singapore, Singapore[4]Yong Loo Lin School of Medicine, National University of Singapore, Singapore[5]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, and Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing, China研究所眼科研究所首都医科大学附属北京同仁医院首都医科大学附属同仁医院[6]Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Mannheim, Germany[7]Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA[8]Centre for Vision Research, University of Sydney, Sydney, NSW, Australia
Diabetic retinopathy is a leading cause of vision impairment and blindness. We systematically reviewed studies published from Jan 1, 1980, to Jan 7, 2018, assessed the methodological quality, and described variations in incidence of diabetic retinopathy by region with a focus on population-based studies that were conducted after 2000 (n= 8, including two unpublished studies). Of these eight studies, five were from Asia, and one each from the North America, Caribbean, and sub-Saharan Africa. The annual incidence of diabetic retinopathy ranged from 2.2% to 12.7% and progression from 3.4% to 12.3%. Progression to proliferative diabetic retinopathy was higher in individuals with mild disease compared with those with no disease at baseline. Our Review suggests that more high-quality population-based studies capturing data on the incidence and progression of diabetic retinopathy with stratification by age and sex are needed to consolidate the evidence base. Our data is useful for conceptualisation and development of major public health strategies such as screening programmes for diabetic retinopathy.
基金:
National Medical Research Council (NMRC), SingaporeNational Medical Research Council, Singapore; State Natural Sciences FundNational Natural Science Foundation of China (NSFC) [81041018]; Natural Sciences Fund of the Beijing government [7092021, 7112031]
第一作者机构:[1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore[2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore[3]Duke-NUS Medical School, National University of Singapore, Singapore
通讯作者:
通讯机构:[1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore[2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore[3]Duke-NUS Medical School, National University of Singapore, Singapore[4]Yong Loo Lin School of Medicine, National University of Singapore, Singapore[*1]Singapore National Eye Centre, Singapore 168751
推荐引用方式(GB/T 7714):
Charumathi Sabanayagam,Riswana Banu,Miao Li Chee,et al.Incidence and progression of diabetic retinopathy: a systematic review[J].LANCET DIABETES & ENDOCRINOLOGY.2019,7(2):140-149.doi:10.1016/S2213-8587(18)30128-1.
APA:
Charumathi Sabanayagam,Riswana Banu,Miao Li Chee,Ryan Lee,Ya Xing Wang...&Tien Y Wong.(2019).Incidence and progression of diabetic retinopathy: a systematic review.LANCET DIABETES & ENDOCRINOLOGY,7,(2)
MLA:
Charumathi Sabanayagam,et al."Incidence and progression of diabetic retinopathy: a systematic review".LANCET DIABETES & ENDOCRINOLOGY 7..2(2019):140-149